107 filings
Page 4 of 6
424B5
2tbav8mwz
12 Jan 22
Prospectus supplement for primary offering
5:21pm
8-K
2cnc5x 48f
10 Nov 21
Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update
4:24pm
8-K
dvxbw6wye728iu0rdqa3
28 Oct 21
Departure of Directors or Certain Officers
10:57am
8-K
cx96n5cgesw2oo451q
20 Sep 21
Departure of Directors or Certain Officers
4:35pm
8-K
n4aww1
11 Aug 21
Vaxcyte Reports Second Quarter 2021 Financial Results and Provides Business Update
4:17pm
S-3ASR
hh4dia5zmczhals2
2 Jul 21
Automatic shelf registration
12:00am
8-K
mqlu83l88fmbfu7sw7vb
3 Jun 21
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
ctp qn1zd
11 May 21
Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update
4:05pm
DEFA14A
mgvcthn8
14 Apr 21
Additional proxy soliciting materials
4:11pm
DEF 14A
jz2m323l184jf3
14 Apr 21
Definitive proxy
4:06pm
S-8
4lm9qve
29 Mar 21
Registration of securities for employees
4:16pm
8-K
un5lfav
29 Mar 21
Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
4:08pm
10-K
tx09nib3
29 Mar 21
Annual report
4:02pm
8-K
6bp 1fpsw6kn4
25 Mar 21
Departure of Directors or Certain Officers
12:00am
8-K
rl8pgg
25 Jan 21
Entry into a Material Definitive Agreement
4:05pm
8-K
x6t7nrvlqzsaiaez3
22 Dec 20
Departure of Directors or Certain Officers
8:15am
8-K
jimt0n rzwz3qr9dzm
12 Nov 20
Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update
4:24pm